Filana Therapeutics, Inc. Financial Flexibility Index

Latest as of June 2026: -0.10x

Filana Therapeutics, Inc. financial flexibility index. Filana Therapeutics, Inc. (FLNA) has a Financial Flexibility Index of -0.10x as of June 2026. Free cash flow of $-3.83 Million (operating CF $-3.85 Million minus capex $21.00K) represents 0% of total liabilities ($40.29 Million).

Financial Flexibility Index

-0.10x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-3.83 Million
Operating CF − Capex

Total Liabilities

$40.29 Million
USD

Capital Expenditures

$21.00K
USD

Financial Flexibility Index of Filana Therapeutics, Inc. (2022–2025)

Financial flexibility index of Filana Therapeutics, Inc. from 2022 to 2025. Historical Financial Flexibility Index trend for Filana Therapeutics, Inc. across 4 annual periods. Explore debt repayment capacity of Filana Therapeutics, Inc. to assess how comfortably operating cash covers total debt obligations.

Filana Therapeutics, Inc. Financial Flexibility Index by Year (2022–2025)

Filana Therapeutics, Inc. financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for Filana Therapeutics, Inc.. For the full cash flow conversion analysis, see cash flow conversion of Filana Therapeutics, Inc..

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.72x $-31.67 Million $-32.25 Million $43.95 Million ▲ +92.7%
2024 -9.88x $-116.83 Million $-116.93 Million $11.83 Million ▼ -71.8%
2023 -5.75x $-81.61 Million $-82.03 Million $14.20 Million ▲ +43.9%
2022 -10.25x $-74.80 Million $-77.51 Million $7.29 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities